Targeting AML with New Generation T-Cell Therapies – Xtalks Life Science Podcast Ep. 162
XTalks
JUNE 5, 2024
Tune into the episode to learn about CERo’s next-gen T-cell technology and its lead therapeutic candidate, a CER T cell product that contains a phagocyte receptor component. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
Let's personalize your content